chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Within a few hours fever and chills, day after 2.5º temperature and headache. Two days after negative temperature -2º and terrible headache and weakness. third day slight fever, weakness and same for fourth day. Injection spot has a rash but no big deal.
headache; fever 100.7 F; malaise; fatigue; aches; This is a spontaneous report from a Pfizer-sponsored program from a contactable physician reported for a patient. A patient of unspecified age and gender received bnt162b2 (BNT162B2, solution for injection, Lot number was not reported) dose number unknown via an unspecified route of administration on 11Mar2021 as dose number unknown, single for COVID-19 immunisation. The patient medical history and concomitant medication was not reported. On Mar2021 the patient experienced headache, fever 100.7 f, malaise, fatigue, aches, and symptoms have not shown signs of getting any better. The patient underwent lab tests and procedures which included body temperature resulted 100.7 Fahrenheit on Mar2021. The clinical outcome of the events was reported as not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Incorrect vaccine for age--17 y.o. given first dose Moderna on 3/22/21, so given second dose Moderna on 4/19/21 as per CDC guidance. No AE.
red marks all over face and hands; felt hot; couldn't sleep; allergy reactions; lost depth perception; psychedelic pattern in vision; insignificant arm pain; Blood pressure increased; Rash on forehead; hives; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red marks all over face and hands), FEELING HOT (felt hot), INSOMNIA (couldn't sleep), HYPERSENSITIVITY (allergy reactions) and ALTERED VISUAL DEPTH PERCEPTION (lost depth perception) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038K20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included METHENAMINE HIPPURATE (HIPREX [METHENAMINE HIPPURATE]) for Bladder infection, NORTRIPTYLINE for Facial pain, ATORVASTATIN, MULTIVITAMIN [VITAMINS NOS] and DENOSUMAB (PROLIA) for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced BLOOD PRESSURE INCREASED (Blood pressure increased), RASH (Rash on forehead) and URTICARIA (hives). On an unknown date, the patient experienced ERYTHEMA (red marks all over face and hands), FEELING HOT (felt hot), INSOMNIA (couldn't sleep), HYPERSENSITIVITY (allergy reactions), ALTERED VISUAL DEPTH PERCEPTION (lost depth perception), VISUAL IMPAIRMENT (psychedelic pattern in vision) and MYALGIA (insignificant arm pain). On 15-Feb-2021, URTICARIA (hives) had resolved. At the time of the report, ERYTHEMA (red marks all over face and hands), FEELING HOT (felt hot), INSOMNIA (couldn't sleep), HYPERSENSITIVITY (allergy reactions), ALTERED VISUAL DEPTH PERCEPTION (lost depth perception), VISUAL IMPAIRMENT (psychedelic pattern in vision), BLOOD PRESSURE INCREASED (Blood pressure increased), RASH (Rash on forehead) and MYALGIA (insignificant arm pain) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure increased: 180/135 (High) 180/135 mmHg.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication used was Benadryl   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: No specific follow-up information recorded. On 28-Apr-2021: NNI, additional info 2 On 28-Apr-2021: Additional info 3 On 29-Apr-2021: No specific follow-up information recorded.
Hives and Swelling of hands, face and arms. Treatment was an epi pen and 60mg of prednisone to be taken daily for 5 days.
This spontaneous case reported by a consumer, describes the occurrence of back pain (it felt like the pain moved), hypokinesia (I could barely move my arm) and arthralgia (whole shoulder itself was hurting) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 044A21A) for COVID-19 immunization. No medical history reported. On Mar 23, 2021, the patient received the first dose of mRNA-1273 (Moderna COVID-19  vaccine), intramuscular; 1 dosage form. On Mar 23, 2021, patient experienced arthralgia (whole shoulder itself was hurting). On Mar 24, 2021, patient experienced back pain (it felt like the pain moved) and hypokinesia (I could barely move my arm). At the time of the report, back pain (it felt like the pain moved), hypokinesia (I could barely move my arm) and arthralgia (whole shoulder itself was hurting): resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported. Reporter did not allow further contact. Most recent follow-up information incorporated above included: On Jun 25, 2021: Telephone contact report received. The outcome of events updated to recovered. Sender's comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
January 2019 was very sick but cannot confirm if it was Covid since no dx. test was available then.   June 19, 2021 Dx with T1D and Hasimoto Covid positive 9/18/21  Daughter reports purple/ blue tint and feeling of also feeling cold and also feeling weird on 5/4/22, this happened multiple times prior to documentation. In the last few weeks, Aug 2022, she is feeling the symptoms again. Today 8/26/2022 as an example. the events last 15min to 1hr.
felt like she was going to lose consciousness. She had this sensation for about 2-3 minutes, then finally did pass out; This is a spontaneous report from a contactable consumer (patient). A 41-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via an unspecified route of administration, administered in Arm Left on 22Apr2021 09:30 (Lot Number: EW0171) as 1st dose, single dose (at age of 41-years-old) for covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient's medical history and concomitant medications were not reported. No pregnant at the time of vaccination. On 10May2021 02:00 AM, the patient woke up at night to use bathroom and felt like she was going to lose consciousness. She had this sensation for about 2-3 minutes, then finally did pass out. After her husband found her, and she regained consciousness, she still had a very intense feeling of passing out for about 20 minutes more despite laying down with her feet up. No treatment was received. Prior to vaccination, the patient did not diagnose with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The second dose of BNT162B2 was on 13May2021 09:30 AM (Lot Number: EW0173, Vaccine location; Left arm) for covid-19 immunisation. Outcome of the event was recovered.
First dose administered 5Feb2021 has not received 2nd dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (First dose administered 5Feb2021 has not received 2nd dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (First dose administered 5Feb2021 has not received 2nd dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (First dose administered 5Feb2021 has not received 2nd dose) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   Treatment information was not provided.
Patient vaccinated on 7/12/2023, vaccine expired on 7/9/2023
The member did not experience any adverse reaction. I realized later that I reconstituted the Yellow Fever with the normal saline instead of the sodium chloride solution provided.
I received the shot at 6 PM my back was a little itchy when I went to bed I woke up at 6 AM and was covered from my chest to my feet as the day went on it got a little worse all the way to my fingertips toes palms of my hands. I went to see my primary care physician they took pictures and were reporting it as well they said they have never seen such a reaction from a vaccine. I also have been very sick and dad been diagnosed with more illnesses since March when I received my first dose on March 9 Then contracted the virus around the 20th and then received shot number two on April 9 again I have been in and out of the hospital and very sick ever cents which is why being on prednisone for the last few months and the diagnosis of  Primary Sjogrens  My primary care sent me to get the third shot ASAP
This spontaneous report was received from a health professional refers to a patient of unknown demographics. On 17-MAR-2015 the patient was vaccinated with PROQUAD (Merck), that was improperly stored. No adverse effects were reported. Outcome of the event was unknown. No product quality complaint (PQC) was involved. Reporter considered the event to be not relate to PROQUAD (Merck). Additional information has been requested.
No adverse symptoms reported; improperly stored vaccines were administered to patient; This spontaneous report was received from a nurse referring to a 4 years-old, patient of unknown gender. The patient's pertinent medical history, concurrent conditions, drug reactions or allergies, and concomitant therapies were not provided.       It was reported that on 03-DEC-2019, that measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # R026719) was under temperature excursion at 6 degrees Fahrenheit (F) to 14 degrees F (-14 degrees centigrade (C) to -10 degrees C) (8.7 F), for a time frame of 50 minutes, and  the previous temperature excursion was at 6 degrees Fahrenheit (F) to 14 degrees F (-14 degrees centigrade (C) to -10 degrees C) (6.9 F) for a timeframe of 50 minutes. On 13-JAN-2020, the patient was vaccinated with an improperly stored (product storage error) measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (lot # R026719 has been verified to be a valid number; expiration date 17-MAR-2020) for prophylaxis (strength, dose, frequency, route of administration, anatomical location were not reported). It was reported that the call was due to data logger. No adverse symptoms were reported.   This is one of the several reports received from the same reporter.; Sender's Comments:  US-009507513-2006USA003313:same reporter US-009507513-2006USA005616: US-009507513-2006USA005617: US-009507513-2006USA005618: US-009507513-1912USA001555: US-009507513-2006USA005620:
completely weak,; everything started to spin; vomiting; headache; nausea; third dose was administered on 17Oct2021; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (completely weak,), VERTIGO (everything started to spin), VOMITING (vomiting), HEADACHE (headache) and NAUSEA (nausea) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025021A, 030A21A and 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cancer (Patient did not had chemotherapy). Concurrent medical conditions included Arthritis and Vasculitis.   On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 17-Oct-2021, the patient experienced ASTHENIA (completely weak,), VERTIGO (everything started to spin), VOMITING (vomiting), HEADACHE (headache), NAUSEA (nausea) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (third dose was administered on 17Oct2021). On 17-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (third dose was administered on 17Oct2021) had resolved. At the time of the report, ASTHENIA (completely weak,), VERTIGO (everything started to spin), VOMITING (vomiting), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.            No concomitant medications were provided. No treatment medications were provided.  Patient had no effects after first and second dose.
C/o on going left arm pain progressing after had flu shot 10/9/18. Initially " just sore arm" that night" took  advil, with some relief but "as days went on the shoulder started to hurt" feels like inside my shoulder is hurting, pain with any movement of the shoulder. No shoulder swelling, nor redness, no fever.
immed p/vax area next to inj site-size of quarter appeared w/redness around inj site-pt was fussy when came in & remained so; DNN applied cold pack
sever headache took Rizatriptan at 1130 pm; woke at night to use restroom and felt dizzy - waited a bit and tried to get back to bed but passed out; woke up what I believe to be a few minutes later (4:30 am I think) laying on bathroom floor; got back in bed; woke at 6:30 am and took another Riza and tried to sleep more; 11:30 am still terrible headache took 400mg ibuprofen; 3:00pm 400mg ibuprofen and 4pm 200 more; no relief; took 1000 Tylenol at 5:00pm; 400mg ibuprofen 9:00pm; headache still severe; 11:30 pm 1000mg Tylenol; slept 5 hours and woke up Oct 23 at 5:45 with severe headache and took 1000mg Tylenol; fell back to sleep and woke at 8:30 am with headache presenting more like a migraine in upper right eyebrow area so took Rizatriptan; felt much better for rest of the day (not 100 % but much much better(; woke with slight headache Oct 24 and took 400mg ibuprofen 10:30 am; Oct 25 slight headache in morning with strange arm tingle/pain on right arm (shot was left arm) may be unrelated
Left eye swollen and very red in morning.  Left side of neck very stiff and painful  Injection was in left arm
pt c/o of pain in right deltoid at site of HPV injection given on June 13, 2019. the pain started right after injection. she has pain that is sharp and constant, it is worsened by sleeping on the area and by lifting heavy things. today, the pain is slightly less than initial week. She sometimes has a feeling of weakness in the entire right arm. She has not tried ibuprofen or other pain relief measures.
Injection 11:30 -6pm soreness of arm, redness and swelling of arm from elbow to shoulder 36 hours started up inner arm into axillary. Chills, fever, lost of appetite, nausea.
This spontaneous case reported by a consumer, describes the occurrence of vaccination complication (problems with the 2 Moderna shots) and feeling abnormal (she felt bad) in a female patient, of unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced vaccination complication (problems with the 2 Moderna shots) and feeling abnormal (she felt bad). At the time of the report, vaccination complication (problems with the 2 Moderna shots) and feeling abnormal (she felt bad) outcome: unknown. Patient reported she had to ask someone to unscrew the top of water bottle for her to get a drink of water. No concomitant medication or treatment information provided.
positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable consumer (patient) via Pfizer sponsored program.   A 65-years-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/lot number: EL3249), via an unspecified route of administration on 14Jan2021 at single dose for COVID-19 immunisation. Medical was none. There were no concomitant medications. The patient got covid positive/the covid-19 virus molecular test was positive on an unspecified date with outcome of unknown. On 20Jan2021 the patient started with the first symptoms of got very sick, had terrible body pain, sharp pain and aches, terrible cough, fever and felt completely like physically collapsed. The patient got positive covid-19 virus molecular test on 23Jan2021 with outcome of recovering. On 22Jan2021 the antigen test was negative. On 23Jan2021 the patient had also a negative flu rapid test.
Left arm extremely swollen to three times its size with erythema. 05/25/07-records received from facility.  Left arm cellulitis.  PE:Left arm swelling. C/O itching, tenderness with arm swollen all around arm and whole length of arm red and swollen with some swelling over shoulder. Very tense, tender and firm. Limited flexion of elbow. Temp 100.2. Right tympanic membrane slightly erythematous.  05/25/07-records received from facility. C/O itching, tenderness with arm swollen all around arm and whole length of arm red and swollen with some swelling over shoulder. Very tense, tender and firm. Limited flexion of elbow. Temp 100.2. Right tympanic membrane slightly erythematous. 05/31/07-DC Summary received:DX: cellulitis immunization reaction to DTaP. Compartment syndrome.
Branch retinal artery occlusion, right eye. 5 day hosp stay determined only credible risk factor was proximate Covid-19 injection, leading to a hypercoaguable state. Until that day he was a manual laborer, landscaping for a living. The stroke work-up was negative, although there was a small PFO, there were no DVTs discover.  Decision to leave PFO opened for now was made since it was ot likely a causative factor. Question 21 in the PDF is not accessible!   5 days spent in hospital.
pt recv vax & devel a mild case of chickenpox;pt had numerous lesions all over body;
12 mo old w/ temp 100.9, two episodes of vomiting, pharyngitis, hx of OM s/p PET.
410PM adm. MMR, VARIVAX, DTAP, IPV.  425 mom returned with pt c/o cough, itchy eyes and face.  Adm. albuterol sulfate inhalation sol. 2.5 mg 440PM.  Pt doing well no complications.  Rx. BENADRYL 15/ml 1 tsp 1 4-6 hr.  R.T.O. if not better.
pt got shots 1230PM & 730PM mom was bathing & started twitching & eyes fixed & convulsed for 35 min; mom gave 1 dose of APAP; pt playing & seemed self until sx; had high pitched crying episode for 2 hrs; cont to have grand mal sz;
Dizzy; This case was reported by a consumer via interactive digital media and described the occurrence of dizziness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced dizziness. On an unknown date, the outcome of the dizziness was unknown.   It was unknown if the reporter considered the dizziness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 28-OCT-2022 Reporter's comment:  This case was reported by patient's via interactive digital media. The patient said could he/she find out why he/she was dizzy after having shingle shot. Additional Supportive Information:  The follow-up would not possible as no contact details were available.
Experienced a sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Experienced a sore arm) in an adult male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Experienced a sore arm). At the time of the report, PAIN IN EXTREMITY (Experienced a sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications was provided by the reporter.  No treatment medications was provided by the reporter.   This case was linked to MOD-2022-516393 (Patient Link).
Extreme fatigue starting a few hours after vaccination and lasting around 22 hours; extreme lightheaded sensation  started when first getting up (around 12:30pm, 19 hours after vaccine) and lasted for 4 hours, involving three fainting spells and an inability to move beyond a few steps without feeling faint, and after about an hour, also involved intense chills lasting for an hour
Swelling from top of arm going down to right above the elbow. Redness and heat as well, soreness. Patient is to use cold compress, ZYRTEC 10 mg daily and use either ZANTAC 150 mg or PEPCID complete along with the ZYRTEC. Patient is to go the ER, if he starts to have trouble breathing, urgent care if the reaction continues to get worse.
PATIENT FELT LIGHT HEADED A FEW MINUTES AFTER INJECTION. BLOOD PRESSURE WAS CHECKED AND SHOWN TO BE SLIGHTLY ELEVATED. PATIENT DRANK SOME WATER AND AFTER A FEW MINUTES BLOOD PRESSURE WAS CHECKED AGAIN AND WAS IN NORMAL RANGE.
Information has been received from a physician referring to unspecified patients of unknown age and gender. Information about medical history and concurrent conditions were unspecified. On an unknown date the patients were vaccinated with improperly stored doses of VAQTA (lot # L030442, expiration date 19-DEC-2016; lot # L032749, expiration date 04-NOV-2016; dose and route were unknown). The temperature excursion for the vaccine was 47 F, time frame was 36 hours. There was no previous temperature excursion. It was not because of a "data logger". No adverse effect was reported. This is one of several reports received from the same source. Additional information has been requested.
Information has been received f rom a nurse practitioner via a company representative referring to a 4 year old patient of unknown gendere. The patient's pertinent medical history, drug reactions/allergies and concomitant medication were not provided. On 29-JUL-2016, the patient was inadvertently administered a dose of ZOSTAVAX (lot #, expiration date, dose and route were unknown (inappropriate schedule of drug administration). No adverse effect was reported. Additional information has been requested.
Dizziness; Weakness; Racing heart; I got really sick for 3 days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), administration date 24Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "Dizziness"; ASTHENIA (non-serious), outcome "unknown", described as "Weakness"; ILLNESS (non-serious), outcome "unknown", described as "I got really sick for 3 days"; PALPITATIONS (non-serious), outcome "unknown", described as "Racing heart".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Both legs became severely swollen especially the rt thigh where the DTP was given;  Mom stated leg was turning blue; Advised to take to ER;